Pharmacokinetics of lomefloxacin in renally compromised patients.
The single-dose pharmacokinetics of orally administered lomefloxacin (400 mg) were studied in normal subjects and in patients with various degrees of renal function. The subjects were classified by creatinine clearance (CLCR) normalized for body surface area: group 1, CLCR of greater than 80 ml/min/...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1990
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172062/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2088191/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.12.2364 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
